Importantly, numbers of Tregs and FOXP3 expression from ALS patients were reduced in rapidly progressing ALS patients, inversely correlated with disease progression rates, and were predictive of future rapid progression[62]. Here, FOXP3 is linked to amyotrophic lateral sclerosis.